Rapid evidence synthesis 127: Efficacy and effectiveness of respiratory syncytial virus vaccines and monoclonal antibodies against lower respiratory tract disease in older adults and infants

Abstract

An in-depth synthesis of what is known based on the best available global research evidence (i.e., evidence syntheses) and local research evidence (i.e., single studies) and may include a scan of experiences from other countries and from Canadian provinces and territories, about the efficacy and effectiveness of respiratory syncytial virus vaccines and monoclonal antibodies against lower respiratory tract disease in older adults and infants in response to a decision-maker's request.